Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

April 10, 2023

Study Completion Date

December 31, 2028

Conditions
Low-grade Glioma
Interventions
DRUG

Temozolomide

Concurrent chemotherapy is to receive oral temozolomide, 75 mg/m2 per day, during radiation therapy. Adjuvant chemotherapy will be treated with six cycles of temozolomide, 150 to 200 mg/m2 per day for five consecutive days, repeated every 4 weeks. There is a 28-day break during radiotherapy and adjuvant temozolomide.

RADIATION

intensity modulated radiation therapy

The radiation dose is 50-54 Gy given in 25-30 fractions (1.8-2.0 Gy once daily, 5 days per week).

Trial Locations (1)

610041

RECRUITING

Xingchen Peng, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER